跳至主要内容
临床试验/CTRI/2024/02/063239
CTRI/2024/02/063239尚未招募Unknown

Comparison of Different Doses of Folic Acid in Reducing Side Effects of Methotrexate in Juvenile Idiopathic Arthritis: A Single-Centre, Open-Label, Randomized Controlled Trial - NI

AIIMS PATNA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 未提供

排除标准

  • Participants were excluded if they had a change in dose or introduction of another DMARD, nonsteroidal anti-inflammatory agent or oral steroid within the preceding month, or intra-articular steroid injection within 1 month before enrolment.
  • 1.Children with a history of hypersensitivity or allergic reactions to folic acid, methotrexate, or other disease-modifying anti-rheumatic drugs (DMARDs).
  • 2.Treatment with higher doses of MTX ( > 20 mg/m2/week).
  • 3.Children with any other autoimmune or rheumatic diseases other than JIA.
  • 4.Children who are already taking a folic acid supplement in a dose of more than 400 mcg per day.
  • 5.Children who have participated in any other clinical trial within the past 3 months.
  • 6.Patients with chronic liver disease or other conditions that could increase the risk of hepatotoxicity.
  • 7.Patients on other DMARDs or Biologicals
  • 8.Preexisting contraindication to MTX (Patients having anemia, severe transaminitis)
  • 9.Those having good disease control on NSAIDs
  • 10.Patients having MAS ( Macrophage Activation Syndrome)

研究者

发起方
AIIMS PATNA

相似试验